Pilipović, Ivan

Link to this page

Authority KeyName Variants
orcid::0000-0002-0642-3106
  • Pilipović, Ivan (2)
Projects

Author's Bibliography

Ageing Affects Thymopoiesis and experimental autoimmune encephalomyelitis development in a strain-dependent manner

Stojić-Vukanić, Zorica; Petrušić, Marija; Pilipović, Ivan; Leposavić, Gordana

(Basel: Krager AG, 2023)

TY  - JOUR
AU  - Stojić-Vukanić, Zorica
AU  - Petrušić, Marija
AU  - Pilipović, Ivan
AU  - Leposavić, Gordana
PY  - 2023
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6491
AB  - Introduction: Considering significance of mechanisms of central tolerance for development of autoimmune diseases, including experimental autoimmune encephalomyelitis (EAE), and suppressive influence of circulating proinflammatory cytokines and alterations in brainthymus communication, characteristic for the central nervous system (CNS) autoimmune diseases, on thymopoiesis, the study interogated putative strain-based thymus-related specificities relevant for the opposite effects of ageing on susceptibility of Dark Agouti (DA) and Albino Oxford (AO) rats to EAE. Methods: Quantitative and qualitative changes in thymopoiesis including underlying mechanisms were examined using flow cytometry and RT-qPCR quantification of mRNAs for molecules relevant for integrity of stroma and T-cell development, respectively. Results: With ageing, differently from DA rats, in AO rats the surface density of CD90, anegative regulator of selection threshold, on thymocytes undergoing lineage commitment was upregulated (consistent with TGF-β expression downregulation), whereas the generation of natural CD4+CD25+Foxp3+ regulatory T cells (nTregs) was impaired reflecting differences in thymic expression of cytokines supporting their development.Additionally, specifically in old AO rats, in whom EAE development depends on IL-17-producing CD8+ T cells, their thymic differentiation was augmented, reflecting augmented thymic IL-4 expression. In turn, differently from old DA rats developing
self-limiting EAE, in age-matched AO rats developing EAE of prolonged duration, EAE development led to impaired generation of nTregs and accumulation of proinflammatory, cytotoxic CD28–CD4+ T cells in the periphery. Discussion: The study indicates that strain differences in age-related changes in the efficacy of central tolerance, in addition to enhanced thymic generation of CD8+ T cells prone to differentiate into IL-17-producing cells, could partly explain the opposite effect of ageing on DA and AO rat susceptibility to EAE induction. Additionally, it suggested that EAE development leading to a less efficient thymic output of CD4+ cells and nTregs in old AO rats than their DA counterparts could contribute to prolonged EAE duration in AO compared with DA rats. Conclusion: The study warns to caution when designing therapeutic interventions to enhance thymic activity in genetically diverse populations, e.g., humans, and interpreting their outcomes. Furthermore, it indicates that CNS autoimmune pathology may additionally worsen thymic involution and age-related immune changes.
PB  - Basel: Krager AG
T2  - Neuroimmunomodulation
T1  - Ageing Affects Thymopoiesis and experimental autoimmune encephalomyelitis development in a strain-dependent manner
VL  - 30
DO  - 10.1159/000535150
SP  - 346
EP  - 373
ER  - 
@article{
author = "Stojić-Vukanić, Zorica and Petrušić, Marija and Pilipović, Ivan and Leposavić, Gordana",
year = "2023",
abstract = "Introduction: Considering significance of mechanisms of central tolerance for development of autoimmune diseases, including experimental autoimmune encephalomyelitis (EAE), and suppressive influence of circulating proinflammatory cytokines and alterations in brainthymus communication, characteristic for the central nervous system (CNS) autoimmune diseases, on thymopoiesis, the study interogated putative strain-based thymus-related specificities relevant for the opposite effects of ageing on susceptibility of Dark Agouti (DA) and Albino Oxford (AO) rats to EAE. Methods: Quantitative and qualitative changes in thymopoiesis including underlying mechanisms were examined using flow cytometry and RT-qPCR quantification of mRNAs for molecules relevant for integrity of stroma and T-cell development, respectively. Results: With ageing, differently from DA rats, in AO rats the surface density of CD90, anegative regulator of selection threshold, on thymocytes undergoing lineage commitment was upregulated (consistent with TGF-β expression downregulation), whereas the generation of natural CD4+CD25+Foxp3+ regulatory T cells (nTregs) was impaired reflecting differences in thymic expression of cytokines supporting their development.Additionally, specifically in old AO rats, in whom EAE development depends on IL-17-producing CD8+ T cells, their thymic differentiation was augmented, reflecting augmented thymic IL-4 expression. In turn, differently from old DA rats developing
self-limiting EAE, in age-matched AO rats developing EAE of prolonged duration, EAE development led to impaired generation of nTregs and accumulation of proinflammatory, cytotoxic CD28–CD4+ T cells in the periphery. Discussion: The study indicates that strain differences in age-related changes in the efficacy of central tolerance, in addition to enhanced thymic generation of CD8+ T cells prone to differentiate into IL-17-producing cells, could partly explain the opposite effect of ageing on DA and AO rat susceptibility to EAE induction. Additionally, it suggested that EAE development leading to a less efficient thymic output of CD4+ cells and nTregs in old AO rats than their DA counterparts could contribute to prolonged EAE duration in AO compared with DA rats. Conclusion: The study warns to caution when designing therapeutic interventions to enhance thymic activity in genetically diverse populations, e.g., humans, and interpreting their outcomes. Furthermore, it indicates that CNS autoimmune pathology may additionally worsen thymic involution and age-related immune changes.",
publisher = "Basel: Krager AG",
journal = "Neuroimmunomodulation",
title = "Ageing Affects Thymopoiesis and experimental autoimmune encephalomyelitis development in a strain-dependent manner",
volume = "30",
doi = "10.1159/000535150",
pages = "346-373"
}
Stojić-Vukanić, Z., Petrušić, M., Pilipović, I.,& Leposavić, G.. (2023). Ageing Affects Thymopoiesis and experimental autoimmune encephalomyelitis development in a strain-dependent manner. in Neuroimmunomodulation
Basel: Krager AG., 30, 346-373.
https://doi.org/10.1159/000535150
Stojić-Vukanić Z, Petrušić M, Pilipović I, Leposavić G. Ageing Affects Thymopoiesis and experimental autoimmune encephalomyelitis development in a strain-dependent manner. in Neuroimmunomodulation. 2023;30:346-373.
doi:10.1159/000535150 .
Stojić-Vukanić, Zorica, Petrušić, Marija, Pilipović, Ivan, Leposavić, Gordana, "Ageing Affects Thymopoiesis and experimental autoimmune encephalomyelitis development in a strain-dependent manner" in Neuroimmunomodulation, 30 (2023):346-373,
https://doi.org/10.1159/000535150 . .

Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model

Radulović, Nataša; Pilipović, Ivan; Stojanović, Ivana D.

(Belgrade: Serbian Biological Society, 2023)

TY  - JOUR
AU  - Radulović, Nataša
AU  - Pilipović, Ivan
AU  - Stojanović, Ivana D.
PY  - 2023
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6472
AB  - Cyclophosphamide (CP) is a cytostatic, widely used to treat different carcinomas and autoimmune diseases. It is
commonly used in experimental designs modeling immunosuppression in laboratory animals, with different approaches for
CP treatment but without a consensus on the dose, timing, and route of administration. We aimed to establish if treatment
with CP in C57BL/6 mice depletes regulatory T cells (Tregs). Tregs are a crucial component of the immune system that
helps maintain immune tolerance and prevent excessive immune reactions. They are significant in autoimmune diseases,
allergies, and immune-related therapies. CP was applied intraperitoneally (i.p.) twice in a 5-day interval in doses of 100 mg/
kg. Monitoring of Treg prevalence in peripheral blood after each treatment and in the spleen after the second treatment with
CP revealed a drop in the number of Tregs after two doses of CP because of the decreased number of total lymphocytes but
not as a specific response of the Tregs. The prevalence of Tregs in peripheral blood after CP treatment mirrored the change
in Treg number in the spleen. CP treatment induced a decrease in the number of CD3+ cells in the spleen while increasing
their proportion, indicating that CP affected the B lymphocyte population rather than T cells. Our results suggest that CP
treatment cannot be used as a specific Treg-depleting agent in the C57BL/6 animal model.
PB  - Belgrade: Serbian Biological Society
T2  - Archive of Biological Sciences
T1  - Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model
IS  - 4
VL  - 75
DO  - 10.2298/ABS230715032R
SP  - 397
EP  - 406
ER  - 
@article{
author = "Radulović, Nataša and Pilipović, Ivan and Stojanović, Ivana D.",
year = "2023",
abstract = "Cyclophosphamide (CP) is a cytostatic, widely used to treat different carcinomas and autoimmune diseases. It is
commonly used in experimental designs modeling immunosuppression in laboratory animals, with different approaches for
CP treatment but without a consensus on the dose, timing, and route of administration. We aimed to establish if treatment
with CP in C57BL/6 mice depletes regulatory T cells (Tregs). Tregs are a crucial component of the immune system that
helps maintain immune tolerance and prevent excessive immune reactions. They are significant in autoimmune diseases,
allergies, and immune-related therapies. CP was applied intraperitoneally (i.p.) twice in a 5-day interval in doses of 100 mg/
kg. Monitoring of Treg prevalence in peripheral blood after each treatment and in the spleen after the second treatment with
CP revealed a drop in the number of Tregs after two doses of CP because of the decreased number of total lymphocytes but
not as a specific response of the Tregs. The prevalence of Tregs in peripheral blood after CP treatment mirrored the change
in Treg number in the spleen. CP treatment induced a decrease in the number of CD3+ cells in the spleen while increasing
their proportion, indicating that CP affected the B lymphocyte population rather than T cells. Our results suggest that CP
treatment cannot be used as a specific Treg-depleting agent in the C57BL/6 animal model.",
publisher = "Belgrade: Serbian Biological Society",
journal = "Archive of Biological Sciences",
title = "Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model",
number = "4",
volume = "75",
doi = "10.2298/ABS230715032R",
pages = "397-406"
}
Radulović, N., Pilipović, I.,& Stojanović, I. D.. (2023). Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model. in Archive of Biological Sciences
Belgrade: Serbian Biological Society., 75(4), 397-406.
https://doi.org/10.2298/ABS230715032R
Radulović N, Pilipović I, Stojanović ID. Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model. in Archive of Biological Sciences. 2023;75(4):397-406.
doi:10.2298/ABS230715032R .
Radulović, Nataša, Pilipović, Ivan, Stojanović, Ivana D., "Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model" in Archive of Biological Sciences, 75, no. 4 (2023):397-406,
https://doi.org/10.2298/ABS230715032R . .